Correlation between morphologic and nonmorphologic prognostic markers of neuroblastoma

Area of Science:

• Oncology
• Pediatric Oncology
• Molecular Biology

Background:

• Neuroblastoma (NB) prognosis is influenced by various morphologic and nonmorphologic markers.
• Understanding these markers is crucial for predicting disease progression and treatment response.
• Nonmorphologic markers play roles in abnormal cell proliferation, drug resistance, and apoptosis.

Purpose of the Study:

• To review and analyze morphologic and nonmorphologic prognostic markers for neuroblastoma (NB).
• To identify statistically significant associations between specific markers and NB characteristics.
• To explore the potential for developing risk-specific therapeutic algorithms based on prognostic markers.

Main Methods:

• Review of morphologic markers: Shimada classification (SC), original and modified histologic grades (OHG and MHG).
• Analysis of nonmorphologic markers: serum LDH, 1p deletion, DNA index, N-myc copy number, telomerase activity, and expression of MRP, MDR1, and TRK.
• Statistical analysis to determine associations between markers and NB features.

Main Results:

• Significant associations found between high OHG/MHG (grade 3), DNA index of 1 (diploidy), N-myc copy number (>1 per haploid genome), and elevated serum LDH (> or = 1500 IU/l) (p < 0.001 for each).
• In SC, undifferentiated histology and high MKI correlate with N-myc amplification.
• No correlation observed between morphology and N-myc amplification in localized NB.

Conclusions:

• Specific nonmorphologic markers (N-myc, LDH, DNA index) and histologic grades are strongly associated with NB prognosis.
• Further validation in larger, prospective studies is needed.
• These findings can guide the identification of NB subsets with reliable prognostic markers for risk-stratified therapy.